448 related articles for article (PubMed ID: 18220761)
1. Virtual screening and its integration with modern drug design technologies.
Guido RV; Oliva G; Andricopulo AD
Curr Med Chem; 2008; 15(1):37-46. PubMed ID: 18220761
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening for the discovery of bioactive natural products.
Rollinger JM; Stuppner H; Langer T
Prog Drug Res; 2008; 65():211, 213-49. PubMed ID: 18084917
[TBL] [Abstract][Full Text] [Related]
3. Modern drug discovery technologies: opportunities and challenges in lead discovery.
Guido RV; Oliva G; Andricopulo AD
Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147
[TBL] [Abstract][Full Text] [Related]
4. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
Tropsha A; Golbraikh A
Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
6. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
Pozzan A
Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
[TBL] [Abstract][Full Text] [Related]
7. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
8. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
10. Current trends in virtual high throughput screening using ligand-based and structure-based methods.
Sukumar N; Das S
Comb Chem High Throughput Screen; 2011 Dec; 14(10):872-88. PubMed ID: 21843144
[TBL] [Abstract][Full Text] [Related]
11. Systematic generation of chemical structures for rational drug design based on QSAR models.
Funatsu K; Miyao T; Arakawa M
Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based QSAR: perspectives in drug design.
Salum LB; Andricopulo AD
Mol Divers; 2009 Aug; 13(3):277-85. PubMed ID: 19184499
[TBL] [Abstract][Full Text] [Related]
15. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
Rodríguez D; Gutiérrez-de-Terán H
Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
[TBL] [Abstract][Full Text] [Related]
16. Virtual high-throughput screening of molecular databases.
Seifert MH; Kraus J; Kramer B
Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
[TBL] [Abstract][Full Text] [Related]
17. [Computational chemistry in structure-based drug design].
Cao R; Li W; Sun HZ; Zhou Y; Huang N
Yao Xue Xue Bao; 2013 Jul; 48(7):1041-52. PubMed ID: 24133970
[TBL] [Abstract][Full Text] [Related]
18. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
20. A cheminformatic toolkit for mining biomedical knowledge.
Rosania GR; Crippen G; Woolf P; States D; Shedden K
Pharm Res; 2007 Oct; 24(10):1791-802. PubMed ID: 17385012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]